Eisai
4523.T
#1949
Rank
HK$65.65 B
Marketcap
HK$232.19
Share price
-0.30%
Change (1 day)
-37.05%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): HK$17.10

According to Eisai's latest financial reports the company's current EPS (TTM) is HK$17.01. In 2022 the company made an earnings per share (EPS) of HK$12.49 a decrease over its 2021 EPS that were of HK$55.45.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$17.1036.89%
2022HK$12.49-77.48%
2021HK$55.45-41.88%
2020HK$95.40-0.94%
2019HK$96.3152.59%
2018HK$63.11124.17%
2017HK$28.15-49.42%
2016HK$55.6737.08%
2015HK$40.61-11.75%
2014HK$46.02-3.23%
2013HK$47.55-18.56%
2012HK$58.39-15.51%
2011HK$69.11-3.75%
2010HK$71.81-1.36%
2009HK$72.80